Skip to main content
OpenTrials

Clinical trial condition

Triple Negative Breast Neoplasms

Explore clinical trials studying Triple Negative Breast Neoplasms. Study availability and eligibility vary by location and protocol.

819 public trials 296 recruiting studies
Refine in advanced search Browse all conditions

Triple Negative Breast Neoplasms trial results

Completed

Cisplatin With or Without Veliparib in Treating Patients With Recurrent or Metastatic Triple-Negative and/or BRCA Mutation-Associated Breast Cancer With or Without Brain Metastases

NCT02595905

Conditions
Brain Diseases, Brain Neoplasms, Breast Diseases, +16 more
Locations
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
  • Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
View all 810 locations
View Trial Details
Completed

A Study of MK-4700 Alone or With Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors (MK-4700-001)

NCT06894771

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +45 more
Locations
  • John Theurer Cancer Center at Hackensack University Medical Center ( Site 0301) Hackensack, New Jersey, United States
  • NEXT Oncology ( Site 0300) San Antonio, Texas, United States
  • Princess Margaret Cancer Center ( Site 0101) Toronto, Ontario, Canada
  • Centre intégré de cancérologie du CHU de Québec Université Laval, Hôpital de l'Enfant-Jésus ( Site 0102) Québec, Quebec, Canada
View Trial Details
Completed

RNA-Immunotherapy of IVAC_W_bre1_uID and IVAC_M_uID

NCT02316457

Conditions
Breast Cancer (Triple Negative Breast Cancer (TNBC)), Breast Diseases, Breast Neoplasms, +5 more
Locations
  • Johannes Gutenberg University Mainz, RLP, Germany
  • National Center for Tumor Diseases (NCT) Heidelberg, Germany
  • Dr. Horst Schmidt-Kliniken Wiesbaden Wiesbaden, Germany
  • Uppsala University Hospital Uppsala, Sweden
View Trial Details
Completed

NT-I7 (Efineptakin Alfa) in Combination With Pembrolizumab in Participants With Advanced Solid Tumors

NCT04332653

Conditions
Adnexal Diseases, Any Advanced Solid Tumors, Breast Diseases, +41 more
Locations
  • Moffit Cancer Center Tampa, Florida, United States
  • Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States
  • Washington University School of Medicine in St. Louis St Louis, Missouri, United States
  • Duke University Medical Center Durham, North Carolina, United States
View Trial Details
Completed

Study of Olaparib Plus Pembrolizumab Versus Chemotherapy Plus Pembrolizumab After Induction With First-Line Chemotherapy Plus Pembrolizumab in Triple Negative Breast Cancer (TNBC) (MK-7339-009/KEYLYNK-009)

NCT04191135

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations
  • Pacific Cancer Care ( Site 0142) Monterey, California, United States
  • UCSF Helen Diller Family Comprehensive Cancer Center ( Site 0138) San Francisco, California, United States
  • John Wayne Cancer Institute ( Site 0111) Santa Monica, California, United States
  • St. Joseph Heritage Healthcare ( Site 0104) Santa Rosa, California, United States
View all 122 locations
View Trial Details

Related conditions